RYARX | RYTPX | RYARX / RYTPX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 21 years | 25 years | - |
Gain YTD | 2.684 | 4.169 | 64% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | 1000 | 1000 | 100% |
Net Assets | 38.8M | 10.6M | 366% |
Annual Yield % from dividends | 3.32 | 3.98 | 84% |
Returns for 1 year | -11.90 | -22.20 | 54% |
Returns for 3 years | -24.77 | -49.24 | 50% |
Returns for 5 years | -57.08 | -85.18 | 67% |
Returns for 10 years | -74.28 | -95.18 | 78% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 70.13 | 1.08 | +1.56% |
Janus Henderson Global Life Sciences A | |||
QCSGX | 18.90 | 0.21 | +1.12% |
Federated Hermes MDT Small Cap Growth C | |||
ARVIX | 10.81 | N/A | N/A |
ARGA International Value Institutional | |||
BSUVX | 10.20 | N/A | N/A |
BlackRock Sustainable US Value Eq Ins | |||
RSGGX | 24.08 | N/A | N/A |
Victory RS Global A |